Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm.

ABSTRACT:

SUBMITTER: Walter RB 

PROVIDER: S-EPMC5830380 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature